After yesterday's event this may have a new meaning if TEVA did use or Procognia's technology to strengthen their generic Lovenox ANDA. Can they still do it now? (Is it possible to add new data after submitting the ANDA?)
On a side note, Procognia's advantage over Momenta's is in biological systems where time to decision is crucial like when doing clone selection (MNTA's tech requires more time and preparations).
On a side note, Procognia's advantage over Momenta's is in biological systems where time to decision is crucial like when doing clone selection (MNTA's tech requires more time and preparations).
Recent PLX News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2026 11:06:20 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2026 10:57:15 AM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/30/2026 08:35:11 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/30/2026 08:30:39 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 03/30/2026 09:31:32 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/18/2026 11:12:44 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/18/2026 10:56:54 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/09/2026 11:51:13 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/11/2026 10:10:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2026 03:09:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2026 11:56:10 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/23/2025 12:25:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 09:34:55 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 11:58:56 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 11:54:59 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2025 09:44:01 PM
- Protalix BioTherapeutics Inc stock plunges after CHMP rejects alternative Elfabrio dosing regimen • IH Market News • 10/17/2025 02:50:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2025 12:08:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/04/2025 09:00:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/04/2025 09:00:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/04/2025 09:00:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/04/2025 09:00:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/04/2025 09:00:14 PM
